L. Marzorati

1.2k total citations
23 papers, 693 citations indexed

About

L. Marzorati is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, L. Marzorati has authored 23 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in L. Marzorati's work include Cancer Treatment and Pharmacology (12 papers), Brain Metastases and Treatment (8 papers) and Microtubule and mitosis dynamics (4 papers). L. Marzorati is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Brain Metastases and Treatment (8 papers) and Microtubule and mitosis dynamics (4 papers). L. Marzorati collaborates with scholars based in Italy, United States and Austria. L. Marzorati's co-authors include G. Bogliun, Guido Cavaletti, A. Zincone, Nicoletta Colombo, G Tredici, Sante Cundari, Andrea Alberto Lissoni, Marco Piatti, Claudio Zanna and N. Colombo and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer.

In The Last Decade

L. Marzorati

22 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Marzorati Italy 13 392 216 143 138 126 23 693
Alessandra Gilardini Italy 11 426 1.1× 81 0.4× 156 1.1× 255 1.8× 62 0.5× 13 707
Francesca Lanzani Italy 6 544 1.4× 224 1.0× 232 1.6× 247 1.8× 223 1.8× 12 801
Barbara Frigeni Italy 16 736 1.9× 196 0.9× 138 1.0× 316 2.3× 313 2.5× 25 1.2k
G Fumagalli Italy 12 326 0.8× 78 0.4× 142 1.0× 93 0.7× 53 0.4× 26 501
C. J. Vecht Netherlands 8 190 0.5× 109 0.5× 45 0.3× 56 0.4× 58 0.5× 17 613
Edvina Galiè Italy 11 184 0.5× 97 0.4× 47 0.3× 68 0.5× 65 0.5× 26 576
Susan Booher United States 12 170 0.4× 132 0.6× 251 1.8× 45 0.3× 50 0.4× 16 847
Stacey Bain United States 6 371 0.9× 42 0.2× 68 0.5× 89 0.6× 148 1.2× 7 477
Madhu P. Menon United States 15 215 0.5× 79 0.4× 245 1.7× 198 1.4× 21 0.2× 39 781
Matthew Rosebraugh United States 9 81 0.2× 151 0.7× 36 0.3× 79 0.6× 59 0.5× 21 513

Countries citing papers authored by L. Marzorati

Since Specialization
Citations

This map shows the geographic impact of L. Marzorati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Marzorati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Marzorati more than expected).

Fields of papers citing papers by L. Marzorati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Marzorati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Marzorati. The network helps show where L. Marzorati may publish in the future.

Co-authorship network of co-authors of L. Marzorati

This figure shows the co-authorship network connecting the top 25 collaborators of L. Marzorati. A scholar is included among the top collaborators of L. Marzorati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Marzorati. L. Marzorati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stanzani, Lorenzo, L. Marzorati, Michela Ripolone, et al.. (2025). Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report. Journal of the Peripheral Nervous System. 30(1). e70010–e70010. 1 indexed citations
2.
Balducci, Claudia, Alessandra Ciervo, Fabiola Mancini, et al.. (2019). Primary Whipple disease of the Central Nervous System presenting with rhombencephalitis. International Journal of Infectious Diseases. 88. 149–151. 5 indexed citations
3.
Guglielmo, Priscilla, et al.. (2017). 18 F-FDG-PET/CT guiding to diagnosis of neurosarcoidosis. Revista Española de Medicina Nuclear e Imagen Molecular. 36(4). 269–270. 1 indexed citations
4.
Saracchi, Enrico, Maria Teresa Bassi, Erika Brighina, et al.. (2014). A novel heterozygous SETX mutation in a patient presenting with chorea and motor neuron disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15(1-2). 138–140. 8 indexed citations
5.
Pagni, Fabio, Giuseppe Isimbaldi, Francesco Vergani, et al.. (2012). Primary angiitis of the central nervous system: 2 atypical cases. Folia Neuropathologica. 3(3). 293–299. 10 indexed citations
6.
Tremolizzo, Lucio, L. Marzorati, Francesca Lanzani, et al.. (2011). Early-onset SCA17 with 43 TBP repeats: expanding the phenotype?. Neurological Sciences. 32(5). 941–943. 4 indexed citations
7.
Marzorati, L., et al.. (2006). Primary progressive multifocal leukoencephalopathy: report of a case.. PubMed. 20(3). 139–42. 5 indexed citations
8.
Cavaletti, Guido, G. Bogliun, L. Marzorati, et al.. (2004). Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy. Annals of Oncology. 15(9). 1439–1442. 90 indexed citations
9.
Cavaletti, Guido, G. Bogliun, L. Marzorati, et al.. (2003). Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale. Neurology. 61(9). 1297–1300. 149 indexed citations
10.
Cavaletti, Guido, G. Bogliun, A. Zincone, et al.. (1999). Neuro- and ototoxicity of high-dose carboplatin treatment in poor prognosis ovarian cancer patients.. PubMed. 18(5B). 3797–802. 29 indexed citations
11.
Drlicek, M., Giovanna Bianchi, G. Bogliun, et al.. (1997). Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. Journal of Neurology. 244(2). 85–89. 57 indexed citations
12.
Cavaletti, Guido, G. Bogliun, Valentino Crespi, et al.. (1997). Neurotoxicity and ototoxicity of cisplatin plus paclitaxel in comparison to cisplatin plus cyclophosphamide in patients with epithelial ovarian cancer.. Journal of Clinical Oncology. 15(1). 199–206. 42 indexed citations
13.
Bogliun, G., L. Marzorati, A. Zincone, et al.. (1997). Risk factors for the development of severe cisplatin neurotoxicity. International Journal of Oncology. 11(2). 365–70. 2 indexed citations
14.
Bogliun, G., et al.. (1996). Neurotoxicity of cisplatin +/- reduced glutathione in the first-line treatment of advanced ovarian cancer. International Journal of Gynecological Cancer. 6(5). 415–419. 23 indexed citations
15.
Colombo, N., Simone Bini, Dario Di Miceli, et al.. (1995). Weekly cisplatin ± glutathione in relapsed ovarian carcinoma. International Journal of Gynecological Cancer. 5(2). 81–86. 40 indexed citations
16.
Cavaletti, Guido, G. Bogliun, L. Marzorati, et al.. (1994). Long-term peripheral neurotoxicity of cisplatin in patients with successfully treated epithelial ovarian cancer.. PubMed. 14(3B). 1287–92. 17 indexed citations
17.
18.
Cavaletti, Guido, et al.. (1992). Cisplatin-lnduced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity. Cancer. 69(1). 203–207. 90 indexed citations
19.
Bogliun, G., L. Marzorati, Guido Cavaletti, & L. Frattola. (1992). Evaluation by somatosensory evoked potentials of the neurotoxicity of cisplatin alone or in combination with glutathione. Neurological Sciences. 13(8). 643–647. 12 indexed citations
20.
Cavaletti, Guido, et al.. (1991). The incidence and course of paraneoplastic neuropathy in women with epithelial ovarian cancer. Journal of Neurology. 238(7). 371–374. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Gilardini Breakdown of academic impact, for papers by Francesca Lanzani Breakdown of academic impact, for papers by Barbara Frigeni Breakdown of academic impact, for papers by G Fumagalli Breakdown of academic impact, for papers by C. J. Vecht Breakdown of academic impact, for papers by Edvina Galiè Breakdown of academic impact, for papers by Susan Booher Breakdown of academic impact, for papers by Stacey Bain Breakdown of academic impact, for papers by Madhu P. Menon Breakdown of academic impact, for papers by Matthew Rosebraugh
Rankless by CCL
2026